Lv1
20 积分 2025-06-03 加入
mRNA lipid nanoparticle formulation, characterization and evaluation
2个月前
已完结
The design, manufacture and LNP formulation of mRNA for research use
2个月前
已完结
The covalent NLRP3-inflammasome inhibitor Oridonin relieves myocardial infarction induced myocardial fibrosis and cardiac remodeling in mice
4个月前
已完结
Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets
4个月前
已完结
Trends in FDA drug approvals: 2021–2024 insights & innovations
5个月前
已完结
Trends in FDA drug approvals: 2021–2024 insights & innovations
5个月前
已关闭
New FDA drug approvals for 2024: Synthesis and clinical application
5个月前
已完结
Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery
6个月前
已完结
In vivo editing of lung stem cells for durable gene correction in mice
10个月前
已完结
Dual SORT LNPs for multi-organ base editing
10个月前
已完结
皖公网安备34019202002308
